181 related articles for article (PubMed ID: 1443870)
1. Effects of natriuretic peptides and neutral endopeptidase 24.11 inhibition in isolated perfused rat lung.
Zhao L; Hughes JM; Winter RJ
Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1198-201. PubMed ID: 1443870
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia.
Winter RJ; Zhao L; Krausz T; Hughes JM
Am Rev Respir Dis; 1991 Dec; 144(6):1342-6. PubMed ID: 1835825
[TBL] [Abstract][Full Text] [Related]
3. C-type natriuretic peptide expression and pulmonary vasodilation in hypoxia-adapted rats.
Klinger JR; Siddiq FM; Swift RA; Jackson C; Pietras L; Warburton RR; Alia C; Hill NS
Am J Physiol; 1998 Oct; 275(4):L645-52. PubMed ID: 9755096
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation.
Höhne C; Drzimalla M; Krebs MO; Boemke W; Kaczmarczyk G
J Physiol Pharmacol; 2003 Dec; 54(4):497-510. PubMed ID: 14726606
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans.
Cargill RI; Lipworth BJ
Br J Clin Pharmacol; 1995 Dec; 40(6):585-90. PubMed ID: 8703666
[TBL] [Abstract][Full Text] [Related]
6. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats.
Barer G; Emery C; Stewart A; Bee D; Howard P
J Physiol; 1993 Apr; 463():1-16. PubMed ID: 8246176
[TBL] [Abstract][Full Text] [Related]
7. Reversal of pulmonary vascular remodelling following hypoxic exposure: no effect of infusion of atrial natriuretic factor and neutral endopeptidase inhibitor.
Zhao L; Hughes JM; Winter RJ
Cardiovasc Res; 1994 Apr; 28(4):519-23. PubMed ID: 8181040
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hypoxic pulmonary vasoconstriction in isolated rat resistance arteries by atrial natriuretic peptide.
Rogers TK; Thompson JS; Morice AH
Eur Respir J; 1997 Sep; 10(9):2061-5. PubMed ID: 9311503
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension.
Hill NS; Klinger JR; Warburton RR; Pietras L; Wrenn DS
Am J Physiol; 1994 Mar; 266(3 Pt 1):L308-15. PubMed ID: 8166300
[TBL] [Abstract][Full Text] [Related]
10. Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats.
Klinger JR; Warburton RR; Pietras L; Hill NS
J Appl Physiol (1985); 1998 May; 84(5):1646-52. PubMed ID: 9572812
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide-induced relaxation of pre-constricted isolated rat perfused lungs: a comparison in control and hypoxia-adapted animals.
Stewart AG; Thompson JS; Rogers TK; Morice AH
Clin Sci (Lond); 1991 Aug; 81(2):201-8. PubMed ID: 1653664
[TBL] [Abstract][Full Text] [Related]
12. Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.
Kirk JE; Wilkins MR
Br J Pharmacol; 1993 Sep; 110(1):350-4. PubMed ID: 8220896
[TBL] [Abstract][Full Text] [Related]
13. The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.
Cargill RI; Lipworth BJ
Br J Clin Pharmacol; 1995 Jul; 40(1):11-8. PubMed ID: 8527262
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans.
Cargill RI; Lipworth BJ
Thorax; 1995 Feb; 50(2):183-5. PubMed ID: 7701460
[TBL] [Abstract][Full Text] [Related]
15. Effects of radiographic contrast media on pulmonary vascular resistance of normoxic and chronically hypoxic pulmonary hypertensive rats.
Emery CJ; Fang L; Laude EA; Morcos SK
Br J Radiol; 2001 Dec; 74(888):1109-17. PubMed ID: 11777768
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects.
Cargill RI; Lipworth BJ
Chest; 1996 Nov; 110(5):1220-5. PubMed ID: 8915224
[TBL] [Abstract][Full Text] [Related]
17.
Cui X; Wang J; Li Y; Couse ZG; Risoleo TF; Moayeri M; Leppla SH; Malide D; Yu ZX; Eichacker PQ
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H36-H51. PubMed ID: 33064559
[No Abstract] [Full Text] [Related]
18. Action of carbon dioxide on hypoxic pulmonary vasoconstriction in the rat lung: evidence against specific endothelium-derived relaxing factor-mediated vasodilation.
Baudouin SV; Evans TW
Crit Care Med; 1993 May; 21(5):740-6. PubMed ID: 8482095
[TBL] [Abstract][Full Text] [Related]
19. Effects of ligustrazine on the pressure/flow relationship in isolated perfused rat lungs.
Oddoy A; Bee D; Emery C; Barer G
Eur Respir J; 1991 Nov; 4(10):1223-7. PubMed ID: 1804670
[TBL] [Abstract][Full Text] [Related]
20. Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.
Thompson JS; Sheedy W; Morice AH
Br J Pharmacol; 1994 Dec; 113(4):1121-6. PubMed ID: 7889263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
